These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37498378)

  • 1. An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis.
    Arega AM; Dhal AK; Pattanaik KP; Nayak S; Mahapatra RK
    Appl Biochem Biotechnol; 2024 Apr; 196(4):2367-2395. PubMed ID: 37498378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis.
    Sethi G; Varghese RP; Lakra AK; Nayak SS; Krishna R; Hwang JH
    Sci Rep; 2024 Jul; 14(1):15923. PubMed ID: 38987613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational discovery and ex-vivo validation study of novel antigenic vaccine candidates against tuberculosis.
    Arega AM; Pattanaik KP; Nayak S; Mahapatra RK
    Acta Trop; 2021 May; 217():105870. PubMed ID: 33636152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of multi-epitope based vaccine against
    Nayak SS; Sethi G; Ramadas K
    J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.
    Logesh R; Lavanya V; Jamal S; Ahmed N
    Appl Biochem Biotechnol; 2022 Jan; 194(1):187-214. PubMed ID: 34817805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
    McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
    Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins.
    Sharma R; Rajput VS; Jamal S; Grover A; Grover S
    Sci Rep; 2021 Jul; 11(1):13836. PubMed ID: 34226593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv.
    Fatma F; Tripathi DK; Srivastava M; Srivastava KK; Arora A
    Tuberculosis (Edinb); 2021 Mar; 127():102054. PubMed ID: 33550109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
    Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
    Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
    Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
    Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
    Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
    Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology.
    Bibi S; Ullah I; Zhu B; Adnan M; Liaqat R; Kong WB; Niu S
    Sci Rep; 2021 Jan; 11(1):1249. PubMed ID: 33441913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling a Comprehensive Multi-epitope Subunit Vaccine Strategy Against Salmonella subsp. enterica: Bridging Core, Subtractive Proteomics, and Immunoinformatics.
    Chand Y; Jain T; Singh S
    Cell Biochem Biophys; 2024 Sep; 82(3):2901-2936. PubMed ID: 39018007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoinformatics-Based Designing of Novel and Potent Multi-Epitope PSA D15 and Cag11 Immunogens for Helicobacter pylori Immunodiagnostic Assay Development.
    Moges Eskeziyaw B; Waihenya R; Maina N; Muuo Nzou S
    Helicobacter; 2024; 29(3):e13104. PubMed ID: 38923222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
    Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
    Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
    Nain Z; Karim MM; Sen MK; Adhikari UK
    Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of immunoinformatics in the development of T-cell peptide-based vaccines against
    Ortega-Tirado D; Arvizu-Flores AA; Velazquez C; Garibay-Escobar A
    Expert Rev Vaccines; 2020 Sep; 19(9):831-841. PubMed ID: 32945209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
    Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
    J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.